Harvest Group Wealth Management, LLC Exelixis, Inc. Transaction History

Harvest Group Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 04, 2021	SELL	$20.53 - $25.22 $205 - $252	-10 Closed	0 $0
Q1 2020 Apr 23, 2020	SELL	$14.46 - $21.8 $1,532 - $2,310	-106 Reduced 91.38%	10 $0
Q4 2019 Jan 27, 2020	SELL	$15.15 - $18.89 $439 - $547	-29 Reduced 20.0%	116 $2,000
Q3 2019 Nov 01, 2019	BUY	$17.68 - $22.65 $495 - $634	28 Added 23.93%	145 $3,000
Q2 2019 Jul 31, 2019	BUY	$18.93 - $24.75 $511 - $668	27 Added 30.0%	117 $2,000
Q1 2019 May 06, 2019	BUY	$19.6 - $24.76 $1,764 - $2,228	90 New	90 $2,000

500

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.1B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Harvest Group Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Group Wealth Management, LLC with notifications on news.